Packing batteries with more punch
Indian researchers are working on cells that can store more energy, last longer
Dr Rathore delivering the Y Subbarow memorial lecture
The Guru Gobind Singh Indraprastha University has decided to establish an endowment in the memory and honour of pioneering Indian biochemist Yellapragada SubbaRow, whose 125th birth anniversary is being celebrated this year.
The announcement was made by university Vice Chancellor Dr Mahesh Verma on the occasion of the 15th Subbarow memorial lecture held in the university. The lecture has been held every year without a break. An exhibition on the life and work of Subbarow was also held on the occasion.
“The contribution of Dr Subbarow to the world of medicine and the humanity is immense and we all owe a debt of gratitude to him for the discovering he made,” Dr Verma observed.
Delivering the memorial lecture on “challenges with development of biotech therapeutics,” Dr Anurag S. Rathore, coordinator of the Centre of Excellence in Biopharmaceutical Technology at IIT Delhi, said “pharmaceuticals today are the biggest exports for India and we are globally regarded as the place for producing economical, safe and efficacious medicines.” The centre has been funded by the Department of Biotechnology (DBT).
During the past decade, he said, there has been significant interest in development of biotherapeutic products. “It remains to be seen if we can replicate our success with pharmaceuticals in this class of products given scientific and regulatory challenges in successful development and commercialization of these products.” These challenges include process development and control, characterization of biotherapeutic products, continuous processing, and multivariate data analysis.
Prof K K Aggarwal, dean of University School of Biotechnology, said the life of Subbarow provides an opportunity to students as well as the faculty to get motivated to serve the humanity through their research contribution.
SubbaRow migrated to Harvard in 1923 from Madras Ayurvedic College and made several medical discoveries and syntheses including the phosphate estimation method (23,900), phosphocreatine, ATP, vitamin folic acid, anti-cancer drugs methotrexate and aminopterin and antibiotic Aureomycin (the parent of tetracycline) and anti-filarial Diethyl Carbamazine many of which are used till date. To recognize SubbaRow and his contribution, The Karolinska Institute in Stockholm, which awards the Nobel Prize in Physiology and Medicine, used to have a portrait of SubbaRow.
Dr Mahesh Verma and SPK Gupta at the exhibition S P K Gupta, biographer of Subbarow, said “he did not get due credit for what he did in the field of molecular biology because the US was then a secondary scientific power to Britain whose science bureaucracy was jealous of maintaining the then position of the United Kingdom. He wanted at one time to continue in India the research he had begun at Harvard but again the British colonialists did not let him have the facilities he needed.” That is why all his path-breaking discoveries of vitamins, antibiotics, anti-cancer treatments and the anti-filarial were made in the US.
Gupta said the lecture series started in 2002 was a landmark and was made possible due to active support of successive deans - Dr K. Kannan, Prof P. C. Sharma and Prof N. Raghuram. He thanked the Vice-chancellor for agreeing to institutionalize this Memorial Lecture series by formal budgeting auniversity endowment. He announced a contribution of Rupees one lakh for the same. (India Science Wire)
Twitter handle: @ndpsr
Indian researchers are working on cells that can store more energy, last longer
To fix a broken bone, doctors often harvest another bone from the patient’s body or from someone else. It ...
Superconductors from IIScScientists at IISc Bangalore have invented a device with a nanocrystal structure ...
Engineering and construction giant L&T has won a licence from the Council of Scientific & Industrial ...
Option price falls more than it rises for the same change in underlying
A long-term vacation here is worth a check-in
The fund delivered a return of 31.5% in 2020 compared with the category’s 15.5%
Care Health Insurance’s new rider offers no great benefit. We review its pros and cons
In these isolated times when people yearn for a slice of the familiar, amateur and professional chefs are ...
While good writing wars against the cliché, television gives it a natural home
India is ready with two vaccines to beat the deadliest virus of recent times. The immunisation drive, however, ...
The storming of the Capitol on January 6 could be the prelude to yet another chapter in the US’s long and ...
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor